USANA Health Sciences Statistics
Share Statistics
USANA Health Sciences has 19.06M shares outstanding. The number of shares has increased by -0.94% in one year.
| Shares Outstanding | 19.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 11.22M |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 477.50K, so 2.51% of the outstanding shares have been sold short.
| Short Interest | 477.50K |
| Short % of Shares Out | 2.51% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 6.07 |
Valuation Ratios
The PE ratio is 16.18 and the forward PE ratio is 16.46. USANA Health Sciences 's PEG ratio is 1.67.
| PE Ratio | 16.18 |
| Forward PE | 16.46 |
| PS Ratio | 1.12 |
| Forward PS | 0.6 |
| PB Ratio | 2.08 |
| P/FCF Ratio | 18.38 |
| PEG Ratio | 1.67 |
Enterprise Valuation
USANA Health Sciences Inc. has an Enterprise Value (EV) of 714.59M.
| EV / Earnings | 11.2 |
| EV / Sales | 0.78 |
| EV / EBITDA | 5.8 |
| EV / EBIT | 7.68 |
| EV / FCF | 12.73 |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.
| Current Ratio | 3.52 |
| Quick Ratio | 3 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.16 |
| Cash Flow / Debt | 89.87 |
| Interest Coverage | 355.23 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 11.35%.
| Return on Equity (ROE) | 0.13% |
| Return on Assets (ROA) | 0.1% |
| Return on Capital (ROIC) | 11.35% |
| Revenue Per Employee | 511.67K |
| Profits Per Employee | 35.44K |
| Employee Count | 1.80K |
| Asset Turnover | 1.46 |
| Inventory Turnover | 2.88 |
Taxes
| Income Tax | 38.66M |
| Effective Tax Rate | 0.38 |
Stock Price Statistics
The stock price has increased by -31.32% in the last 52 weeks. The beta is 0.89, so USANA Health Sciences 's price volatility has been higher than the market average.
| Beta | 0.89 |
| 52-Week Price Change | -31.32% |
| 50-Day Moving Average | 37.53 |
| 200-Day Moving Average | 41.25 |
| Relative Strength Index (RSI) | 36.74 |
| Average Volume (20 Days) | 102.24K |
Income Statement
In the last 12 months, USANA Health Sciences had revenue of 921.01M and earned 63.79M in profits. Earnings per share was 3.31.
| Revenue | 921.01M |
| Gross Profit | 744.32M |
| Operating Income | 93.07M |
| Net Income | 63.79M |
| EBITDA | 123.11M |
| EBIT | 93.07M |
| Earnings Per Share (EPS) | 3.31 |
Balance Sheet
The company has 330.42M in cash and 13.21M in debt, giving a net cash position of 317.21M.
| Cash & Cash Equivalents | 330.42M |
| Total Debt | 13.21M |
| Net Cash | 317.21M |
| Retained Earnings | 445.22M |
| Total Assets | 671.31M |
| Working Capital | 336.41M |
Cash Flow
In the last 12 months, operating cash flow was 70.64M and capital expenditures -14.49M, giving a free cash flow of 56.15M.
| Operating Cash Flow | 70.64M |
| Capital Expenditures | -14.49M |
| Free Cash Flow | 56.15M |
| FCF Per Share | 2.92 |
Margins
Gross margin is 80.82%, with operating and profit margins of 10.11% and 6.93%.
| Gross Margin | 80.82% |
| Operating Margin | 10.11% |
| Pretax Margin | 11.12% |
| Profit Margin | 6.93% |
| EBITDA Margin | 13.37% |
| EBIT Margin | 10.11% |
| FCF Margin | 6.1% |
Dividends & Yields
USNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 9.86% |
| FCF Yield | 8.78% |
Analyst Forecast
The average price target for USNA is $38, which is 13.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $38 |
| Price Target Difference | 13.2% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Nov 23, 2016. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 23, 2016 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 6.3 |
| Piotroski F-Score | 7 |